Form 4: 23andMe Executive William G. Richards Reports Stock Transaction
SEC Form 4 Filing
William G. Richards, Head of Therapeutics Discovery at 23andMe, reports the disposition of 16,106 shares of Class A Common Stock to cover tax obligations.
Summary
- On May 20, 2024, William G. Richards, Head of Therapeutics Discovery at 23andMe Holding Co., disposed of 16,106 shares of Class A Common Stock.
- The transaction was executed to cover tax obligations at a price of $0.5466 per share.
- Following the transaction, Richards directly owns 630,434 shares of 23andMe's Class A Common Stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects a routine transaction to cover tax obligations, with no indication of positive or negative implications for the company's performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard procedure for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 05/20/2024 | Date of stock transaction (disposal of shares). |
| 05/21/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.